Portal de Periódicos da CAPES

Cell Type‐Specific Involvement of Furin in Membrane Type 1 Matrix Metalloproteinase‐Mediated Progelatinase A Activation

1999; Wiley; Volume: 878; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1999.tb07770.x

1749-6632

Takashi Sato, Takayuki Kondo, Motoharu Seiki, Akira Itô,

Enzyme Production and Characterization

Annals of the New York Academy of SciencesVolume 878, Issue 1 p. 713-715 Cell Type-Specific Involvement of Furin in Membrane Type 1 Matrix Metalloproteinase-Mediated Progelatinase A Activation TAKASHI SATO, Corresponding Author TAKASHI SATO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, Japan Address for correspondence: Takashi Sato, Ph.D., Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan. Phone, (81) 426-76-5728; fax, (81) 426-76-5734; e-mail: satotak@ps.toyaku.ac.jpSearch for more papers by this authorTAKAYUKI KONDO, TAKAYUKI KONDO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, JapanSearch for more papers by this authorMOTOHARU SEIKI, MOTOHARU SEIKI Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato, Tokyo 108-0071, JapanSearch for more papers by this authorAKIRA ITO, AKIRA ITO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, JapanSearch for more papers by this author TAKASHI SATO, Corresponding Author TAKASHI SATO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, Japan Address for correspondence: Takashi Sato, Ph.D., Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan. Phone, (81) 426-76-5728; fax, (81) 426-76-5734; e-mail: satotak@ps.toyaku.ac.jpSearch for more papers by this authorTAKAYUKI KONDO, TAKAYUKI KONDO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, JapanSearch for more papers by this authorMOTOHARU SEIKI, MOTOHARU SEIKI Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato, Tokyo 108-0071, JapanSearch for more papers by this authorAKIRA ITO, AKIRA ITO Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo 192-0392, JapanSearch for more papers by this author First published: 06 February 2006 https://doi.org/10.1111/j.1749-6632.1999.tb07770.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume878, Issue1INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONSJune 1999Pages 713-715 RelatedInformation